APWM
NERV icon

Atlas Private Wealth Management’s Minerva Neurosciences NERV Stock Holding History

Atlas Private Wealth Management’s Portfolio NERV Stock Details NERV Fund Activity
Bought
Maintained
Sold
Quarter Market Value Status Shares Change in
Stake 		Trade Value Portfolio Weight Portfolio Position
2020
Q3 		– Sell
-50
Closed -$1K – 444
2020
Q2 		$1K Buy
+50
New +$2.93K ﹤0.01% 439
2020
Q1 		– Sell
-31
Closed -$2K – 472
2019
Q4 		$2K Buy
+31
New +$1.37K ﹤0.01% 432

Other funds holding NERV

Federated Hermes
Federated Hermes Pittsburgh, Pennsylvania $61.5B AUM 30.7% 1-Year Est. Return
Vanguard Group
Vanguard Group Malvern, Pennsylvania $6.9T AUM 27.45% 1-Year Est. Return
BlackRock
BlackRock New York $5.72T AUM 30.48% 1-Year Est. Return
Acadian Asset Management
Acadian Asset Management Boston, Massachusetts $70.5B AUM 36% 1-Year Est. Return
Dimensional Fund Advisors
Dimensional Fund Advisors Austin, Texas $481B AUM 30.42% 1-Year Est. Return
Goldman Sachs
Goldman Sachs New York $871B AUM 31.28% 1-Year Est. Return
OM
Opaleye Management Boston, Massachusetts $759M AUM 124.8% 1-Year Est. Return
AG
Artal Group Luxembourg $1.01B AUM 29.84% 1-Year Est. Return
Renaissance Technologies
Renaissance Technologies New York $63.9B AUM 45.56% 1-Year Est. Return
State Street
State Street Boston, Massachusetts $2.9T AUM 29.55% 1-Year Est. Return

Atlas Private Wealth Management's NERV Position: Q3 2020 in Review

Atlas Private Wealth Management sold out of Minerva Neurosciences (NERV) in Q3 2020, closing a stake of 50 shares — an estimated $1K sold.

Atlas Private Wealth Management first reported a position in NERV in Q4 2019 and held it in 2 quarters. The position peaked at $2K in Q4 2019. 76 funds tracked by Wall St. Rank hold NERV as of Q3 2020.

  • Atlas Private Wealth Management reported no remaining Minerva Neurosciences position as of Q3 2020 after selling out during the quarter.
  • Atlas Private Wealth Management sold 50 Minerva Neurosciences shares in Q3 2020, an estimated $1K.
  • Atlas Private Wealth Management first reported a position in Minerva Neurosciences in Q4 2019 and held it in 2 quarters.
  • Atlas Private Wealth Management's Minerva Neurosciences position peaked at $2K in Q4 2019.
  • 76 funds tracked by Wall St. Rank held Minerva Neurosciences as of Q3 2020.

Based on Atlas Private Wealth Management's 13F filing for Q3 2020, filed 5 Nov 2020.